Cite
Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: Results from a 12-month observational study.
MLA
Soyka, Michael, et al. “Buprenorphine-Naloxone Treatment in Opioid Dependence and Risk of Liver Enzyme Elevation: Results from a 12-Month Observational Study.” American Journal on Addictions, vol. 23, no. 6, Nov. 2014, pp. 563–69. EBSCOhost, https://doi.org/10.1111/j.1521-0391.2014.12131.x.
APA
Soyka, M., Backmund, M., Schmidt, P., & Apelt, S. (2014). Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: Results from a 12-month observational study. American Journal on Addictions, 23(6), 563–569. https://doi.org/10.1111/j.1521-0391.2014.12131.x
Chicago
Soyka, Michael, Markus Backmund, Peggy Schmidt, and Sabine Apelt. 2014. “Buprenorphine-Naloxone Treatment in Opioid Dependence and Risk of Liver Enzyme Elevation: Results from a 12-Month Observational Study.” American Journal on Addictions 23 (6): 563–69. doi:10.1111/j.1521-0391.2014.12131.x.